Hikma Highlights Long-Term Importance Of Biosimilars
CEO Siggi Olafsson Discusses The Evolution Of Hikma’s Injectables Business
• By David Wallace
Hikma sees biosimilars becoming a significant part of its business from 2025 • Source: Olivier Le Moal / Alamy Stock Photo 
